CMS Releases HCPCS Code April Update
The scheduled release of modifications to the HCPCS Level II code set are available on the Centers for Medicare & Medicaid Services’ HCPCS Quarterly Update web page.
Here’s the list of C codes included in the April update.
|HCPCS Code||Long Description||Added Date||Termination Date||Comments|
|C1725||Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)||04/01/2001||Report drug-coated transluminal angioplasty catheters with HCPCS code C2623.|
|C2623||Catheter, transluminal angioplasty, drug-coated, non-laser||04/01/2015||New OPPS pass-through device.|
|C9136||Injection, factor viii, fc fusion protein, (recombinant), per i.u.||01/01/2015||03/31/2015||HCPCS code C9136 will be replaced with HCPCS code Q9975 (Injection, Factor VIII, FC Fusion Protein (Recombinant), per iu) effective April 1, 2015.|
|C9445||Injection, c-1 esterase inhibitor (recombinant), Ruconest, 10 units||04/01/2015||New OPPS pass-through drug code.|
|C9448||Netupitant 300mg and palonosetron 0.5 mg, oral||04/01/2015||New OPPS pass-through drug code.|
|C9449||Injection, blinatumomab, 1 mcg||04/01/2015||New OPPS pass-through drug code.|
|C9450||Injection, fluocinolone acetonide intravitreal implant, 0.01 mg||04/01/2015||New OPPS pass-through drug code.|
|C9451||Injection, peramivir, 1 mg||04/01/2015||New OPPS pass-through drug code.|
|C9452||Injection, ceftolozane 50 mg and tazobactam 25 mg||04/01/2015||New OPPS pass-through drug code.|
Here is the list of “other” codes included in the April update that are added, as of April 1, 2015.
|HCPCS Code||Long Description||Action||Coverage||Effective Date|
|Q9975||“Injection, Factor VIII, FC Fusion Protein (Recombinant), per iu”||Add||D||04/01/2015|
Here’s the list of “other” codes included in the quarterly update that are added or deleted, as of July 1, 2015.
|HCPCS Code||Long Description||Action||Coverage||Pricing||Effective
|Q5101||Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram||Add||D||51||3/1/15|
|Q9976||Injection, Ferric Pyrophosphate Citrate Solution, 0.1 mg of iron||Add||C||51||7/1/15|
|Q9977||Compounded Drug, Not Otherwise Classsified||Add||D||51||7/1/15|
|Q9978||Netupitant 300 mg and Palonosetron 0.5 mg, oral||Add||D||51||7/1/15|
|S8262||Mandibular Orthopedic Repositioning Device, Each||Discontinue||I||0||6/30/15|
Latest posts by Renee Dustman (see all)
- Quality Reporting Measures Under Consideration - November 23, 2016
- New Tool Improves QPP Transparency and Interoperability - November 17, 2016
- CMS Reveals Little-Known Facts About MIPS - November 16, 2016